(NASDAQ: CTKB) Cytek Biosciences's forecast annual revenue growth rate of 15.72% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.7%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.39%.
Cytek Biosciences's revenue in 2024 is $193,015,000.On average, 3 Wall Street analysts forecast CTKB's revenue for 2024 to be $29,219,032,515, with the lowest CTKB revenue forecast at $26,845,098,959, and the highest CTKB revenue forecast at $33,450,406,203. On average, 3 Wall Street analysts forecast CTKB's revenue for 2025 to be $34,733,790,320, with the lowest CTKB revenue forecast at $31,253,870,084, and the highest CTKB revenue forecast at $40,382,773,619.
In 2026, CTKB is forecast to generate $36,578,409,692 in revenue, with the lowest revenue forecast at $36,578,409,692 and the highest revenue forecast at $36,578,409,692.